Nimesulid Mcc (Nimesulide)

Nimesulide acts on inflammatory pathways to relieve symptoms in several common conditions.

• Pain relief: reduces mild to moderate acute pain such as dental or musculoskeletal discomfort.
• Inflammation reduction: diminishes swelling and inflammation in conditions like sprains or soft‑tissue injuries.
• Fever reduction: lowers elevated body temperature associated with febrile illnesses.

• Nimesulide reversibly inhibits the cyclooxygenase‑2 (COX‑2) enzyme, decreasing the conversion of arachidonic acid to prostaglandins. This reduction in prostaglandin synthesis leads to lowered inflammation, pain signaling, and fever response without markedly affecting COX‑1 mediated protective gastric functions.

Nimesulide may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects

• Gastrointestinal discomfort: nausea, dyspepsia, or abdominal pain.
• Headache: mild to moderate intensity.
• Dizziness or vertigo.
• Skin rash or mild pruritus.
• Elevated liver enzymes: transient laboratory changes.

Serious or Rare Side Effects

• Hepatotoxicity: severe liver injury or jaundice.
• Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis.
• Renal impairment: acute kidney injury.
• Allergic anaphylaxis: rapid onset of respiratory or circulatory collapse.
• Blood dyscrasias: agranulocytosis or thrombocytopenia.

Before prescribing Nimesulide, consider the following safety measures.

• Liver function monitoring: assess baseline enzymes and repeat if therapy is prolonged.
• Renal function assessment: evaluate creatinine clearance in patients with kidney disease.
• Gastrointestinal risk: avoid in individuals with active ulcers or a history of severe GI bleeding.
• Concomitant NSAIDs: do not combine with other non‑steroidal anti‑inflammatory drugs to reduce toxicity risk.
• Pregnancy and lactation: avoid use unless clearly indicated by a healthcare professional.
• Store at ambient temperature: keep below 25°C in the original packaging, protected from moisture and direct sunlight.

Nimesulide can interact with several medicines, altering efficacy or safety.

Major Interactions (Avoid)

• Anticoagulants (e.g., warfarin): increased bleeding risk.
• Hepatotoxic drugs (e.g., isoniazid, methotrexate): heightened liver injury potential.
• CYP2C9 inhibitors (e.g., fluconazole): may raise Nimesulide plasma levels.

Moderate Interactions (Monitor Closely)

• Other NSAIDs or aspirin: additive gastrointestinal toxicity.
• Diuretics and ACE inhibitors: possible reduction in renal perfusion.
• Lithium: NSAIDs may increase lithium concentrations.
• Corticosteroids: enhanced risk of ulceration.